Evidence map›Paper›PMID 21042715›Full record

ArticleInternational journal of oncology2010

Cyclin D1 and cyclin D-dependent kinases enhance oral keratinocyte proliferation but do not block keratinocyte differentiation.

Michael Woods, Rima Pant, Sanjay M Mallya

Open access · bronzeAbstract read
In one paragraph

Article in International journal of oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. The Role of p16International journal of molecular sciences · 2017
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael WoodsSchool of Dentistry, University of California, Los Angeles, Los Angeles, CA 90095-1668, USA.
Rima Pant
Sanjay M Mallya
University of California, Los Angeles · US

Funding

SKELETAL, CRANOFACIAL AND ORAL BIOLOGY TRAIINING GRANTT32DE007302 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LURIE, ALAN GORDON · 1996 to 2010
$6.1M
Cyclin D1 in oral carcinogenesisK22DE014773 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MALLYA, SANJAY M · 2002 to 2006
$648k
NIDCR NIH HHS DE007302NIDCR NIH HHS DE014773NIDCR NIH HHS K22 DE014773NIDCR NIH HHS T32 DE007302
6 · The paper itself

Abstract

Maintenance of oral epithelial homeostasis requires a fine balance between cell proliferation and differentiation. However, the molecular mechanisms that couple these processes, and its deregulation in tumorigenesis are not fully understood. Cyclin D1 and its kinase partners CDK4 and CDK6 play an important role in regulating the G1-S phase of the cell cycle. Deregulation of cyclin D1 is a frequent event in oral squamous cell carcinoma. Here, we examined whether overexpression of cyclin D1, CDK4 and CDK6 can deregulate the link between oral keratinocyte proliferation and differentiation. Our results show that cyclin D1 and its kinase partners CDK4 and CDK6 enhance keratinocyte proliferation, but are not sufficient to block calcium-induced keratinocyte differentiation and suggest that deregulation of these G1-regulatory kinases alone is insufficient to uncouple the link between proliferation and differentiation.

Indexed as

Cell ProliferationCarcinoma, Squamous CellCell DifferentiationCyclin D1Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Gene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHumansKeratinocytesMouth MucosaMouth NeoplasmsTransfectionUp-RegulationCyclin D1Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6

Identifiers

PMID21042715
PMCPMC3057756
OpenAlexW2156282062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.